Botox has therapeutic applications well beyond cosmetic wrinkle treatment — and chronic migraine relief is one of the most evidence-supported. Korean dermatology, neurology, and pain-management clinics offer therapeutic Botox using the FDA-approved PREEMPT protocol for chronic migraine. This guide covers what therapeutic Botox actually does for migraine, who qualifies, and how Korean clinics deliver it.
What chronic migraine is
- Defined as 15+ headache days per month, with at least 8 having migraine features.
- Typically lasts 4 hours or more per episode.
- Often associated with nausea, light/sound sensitivity, visual aura.
- Affects daily function, work productivity, quality of life.
- Different from episodic migraine (less than 15 headache days/month).
How Botox works for migraine
The mechanism differs from cosmetic Botox use:
- Blocks release of pain neurotransmitters (CGRP, substance P) at sensory nerve endings.
- Reduces signal transmission from peripheral nerves to brain.
- Prevents migraine onset rather than treating active migraine.
- Effects build over 2–4 weeks; peak effect at 8–12 weeks.
- Cumulative benefit with repeated treatment cycles.
The PREEMPT protocol
FDA-approved standard for chronic migraine Botox:
- 155 units of botulinum toxin per session.
- 31 specific injection sites across forehead, temples, sides of head, neck, and shoulders.
- Sessions repeated every 12 weeks.
- Standardized injection points and dosing.
- Performed by trained physicians.
Therapeutic vs. cosmetic Botox
| Aspect | Cosmetic | Migraine therapeutic |
|---|---|---|
| Goal | Wrinkle reduction | Pain prevention |
| Dose | 20–60 units typical | 155 units (PREEMPT) |
| Injection sites | 5–15 sites | 31 sites |
| Frequency | Every 3–4 months | Every 12 weeks |
| Provider | Cosmetic dermatology/PS | Neurology, pain medicine, headache specialists |
| Effect timing | Days to weeks | 2–4 weeks for benefit |
Who is a good candidate
- Confirmed chronic migraine diagnosis by neurologist.
- 15+ headache days monthly with migraine features.
- Failed adequate trials of preventive medications.
- Willingness to commit to multi-cycle treatment (full benefit may take 2–3 cycles).
- No contraindications (neuromuscular disease, allergies).
Realistic expectations
- Approximately 50% of treated patients experience meaningful reduction in headache days.
- Effect often modest in early cycles, more substantial after 2–3 cycles.
- Doesn\'t typically eliminate all headaches.
- Combined with other migraine management (lifestyle, medications, triggers).
- Effective specifically for chronic migraine; less evidence for episodic.
Korean clinic landscape
Therapeutic migraine Botox in Korea is offered by:
- Specialist headache clinics within hospitals.
- Neurology clinics with cosmetic-procedure capability.
- Some specialized dermatology and pain-medicine clinics in Gangnam.
- University hospital headache centers (most established).
Why some patients consider Korea
- Competitive pricing relative to US.
- Comprehensive evaluation by specialty teams.
- Korean botulinum toxin brands at competitive prices.
- Combination with cosmetic Botox if also desired.
- Multi-trip treatment continuity feasible.
Pre-treatment evaluation
- Headache diary documentation (typically 1–3 months before treatment).
- Neurologist confirmation of chronic migraine diagnosis.
- Review of failed preventive medications.
- Baseline assessment of headache frequency and intensity.
- Discussion of other treatment options (CGRP antagonists, others).
The session experience
- 15–30 minute procedure.
- Topical numbing or scalp cooling.
- 31 injections distributed per PREEMPT protocol.
- Mild discomfort during injection.
- Brief site soreness for hours afterward.
- Return to normal activity immediately.
Recovery and side effects
- Mild scalp tenderness 24–48 hours.
- Possible mild bruising at injection sites.
- Temporary neck weakness in some patients (typically resolves).
- Headache may worsen briefly before improving.
- No restrictions on physical activity.
Risks specific to migraine Botox
- Neck weakness if anatomy causes spread.
- Difficulty swallowing (rare; requires evaluation).
- Allergic reactions (rare).
- Asymmetric facial expression if dosing is uneven.
- Antibody resistance with long-term use (small minority).
Combination with cosmetic Botox
Many patients combine therapeutic and cosmetic uses:
- Same procedure session can include both indications.
- Different injection sites for different purposes.
- Some overlap in forehead area.
- Coordinator must ensure proper dosing for each purpose.
- Cost-efficient combination compared with separate sessions.
Continuity considerations for international patients
- Treatment requires every-12-week sessions for sustained benefit.
- Initial diagnosis and protocol design at Korean clinic.
- Continuity treatment may need home-country provider.
- Documentation of dosing protocol useful for transition.
- Some patients return to Korea for treatment on regular schedule.
What to ask in your consultation
- Do you use the standard PREEMPT protocol?
- Who specifically performs the injections (neurologist, pain specialist)?
- What is the expected response based on my migraine pattern?
- How many cycles before assessing meaningful benefit?
- What is the protocol for ongoing care?
- Should this be combined with other migraine medications?
Pricing in Korea (2026, USD)
- PREEMPT protocol session (155 units): $400–$1,500.
- Korean brand vs. imported brand affects pricing.
- Typically 30–60% less than US pricing.
- Annual cost (4 sessions): $1,500–$5,000.
- Initial consultation and evaluation separate.
Insurance considerations
- Korean residents may have insurance coverage for chronic migraine Botox.
- International patients pay out of pocket typically.
- Some home-country insurances cover migraine Botox; verify before procedure.
- Documentation supports any insurance claims.
Other therapeutic Botox uses in Korea
Beyond migraine:
- TMJ disorder and bruxism (covered separately).
- Hyperhidrosis (covered separately).
- Spasticity in various conditions.
- Cervical dystonia.
- Strabismus and blepharospasm.
- Overactive bladder.
The honest framing
Therapeutic Botox for chronic migraine is well-evidenced and offered competitively in Korea. The treatment requires sustained commitment (multiple cycles) and proper diagnosis confirmation. Patients with confirmed chronic migraine who have failed preventive medications often achieve meaningful headache reduction. International patients can initiate treatment in Korea with continuity at home country, or maintain treatment through repeat Korea trips. Combined with appropriate medical management and lifestyle factors, therapeutic Botox is a meaningful tool for chronic migraine that Korean clinics deliver effectively.